Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gyros Protein Technologies Holding AB

Division of Mesa Laboratories Inc.
www.gyros.com

Latest From Gyros Protein Technologies Holding AB

Recent Financings of Private Companies (07/2009)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Recent Dealmaking (02/2004)

Summarizing the month in European dealmaking.

Gyros AB

A Swedish spin on microfluidics.
BioPharmaceutical Europe

Selected Start-Ups (02/01)

In Vivo summarizes the technology of several recently founded companies: Clinsights Inc. provides web-based post-market clinical and sales support for medical device and pharmaceutical companies and physicians. CombinatoRx Inc. hopes to develop the next generation of pharmaceuticals using new theories of how therapeutics should interact with the complex components of cells. Gyros AB has developed technology for miniaturizing and integrating routine and non-routine laboratory processes on disposable CDs. Innovative Drug Delivery Systems Inc. will develop and commercialize unique nasally administered compounds to treat acute and chronic pain and their associated symptoms. PhytaGenics will use its proprietary rapid, high-volume transgenic production technology to create recombinant biopharmaceutical proteins in plants. StemCo Biomedical Inc.'s stem cell platform is capable of identifying and isolating healthy stem cells from contaminating cells, and can be used in repopulating blood systems or regenerating organs and tissue.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
    • Nanotechnology, Chips, etc.
    • Synthesis Technologies, Production Processes
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Gyros AB
  • Protein Technologies Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Mesa Laboratories Inc.
  • Senior Management
  • Dan Calvo, Pres. & CEO
    Erik Wiberg, CFO & VP, Bus. Support
    Catherine Flagg, VP, American Sales & US Ops.
    Mark Vossenaar, PhD, VP, Sales Europe
    Peter Luk, VP, Sales Asia Pacific
  • Contact Info
  • Gyros Protein Technologies Holding AB
    Phone: (46) 1856 6300
    Dag Hammarskjoldsvag 54
    Uppsala, SE-751 83
    Sweden
UsernamePublicRestriction

Register